Narrow spectrum kinase inhibitors demonstrate promise for the treatment of dry eye disease and other ocular inflammatory disorders

Suzanne Hagan, Matthew C.T. Fyfe, Boatemaa Ofori-Frimpong, Katherine Oliver, Martyn R. Foster, Sameer Sirohi, Yemisi Solanke, Michael Doughty, Adele Rowley, Mike Taylor, Steve Webber, Claire A. Walshe^*

^*Corresponding author for this work